2014 International CES

LAS VEGAS - Wednesday, January 8th 2014 [ME NewsWire]

Dolby Laboratories, Inc. (NYSE:DLB) today announced Dolby® Vision, a new imaging technology that helps content creators and television manufacturers deliver true-to-life brightness, colors, and contrast by augmenting the fidelity of Ultra HD (UHD) and HD video signals for over-the-top (OTT) online streaming, broadcast, and gaming applications. Content mastered and color-graded in Dolby Vision can be seen at this week’s 2014 International CES® event on the latest UHD and HD TVs from Sharp and TCL Multimedia. Both companies are exhibitors in the Las Vegas Convention Center’s Central Hall: Sharp at booth 10916 and TCL at booth 9825. TVs featuring Dolby Vision technology are expected to be available for retail purchase later this year.

"By dramatically enhancing picture quality, Dolby Vision will drive adoption of UHD 4K displays with a winning combination of more and better pixels,” s ... Read more »

ME Newswire / Businesswire

BOUDRY, Switzerland - Tuesday, January 7th 2014

First new treatment to be approved for pancreatic cancer in nearly seven years, highlighting the challenges and unmet needs in treating the disease

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Commission (EC) has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.1

During the last few decades, little progress has been made in improving outcomes for patients diagnosed with pancreatic cancer. According to the European Cancer Observatory, 78,654 people were diagnosed with pancreatic cancer in the EU in 2012, and 77,940 died that same year.2 The mortality of pancreatic cancer is high, making it the fourt ... Read more »

ME NewsWire / Business Wire

RESEARCH TRIANGLE PARK, N.C - Tuesday, January 7th 2014

Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the fourth quarter of 2013 prior to its investor call on Thursday, February 13, 2014, at 8 a.m. EST to discuss fourth quarter financial results and to provide 2014 financial guidance.

The conference call will be accessible, live via webcast, through the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call.

An archived edition of the conference call will be available online at www.quintiles.com/investors after 1 p.m. EST on Thursday, February 13th.

About Quintiles

Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and comme ... Read more »